Liquet Technologies
Liquet Technologies is an Athens, Texas-based ophthalmic medical device company that manufactures the CE-approved CataPulse® Lens Removal System, a cataract surgery platform using High Frequency Pulsed Vacuum technology, serving cataract surgeons and surgical centers globally via direct sales and inherited MED-LOGICS distribution.
- Company typePrivate
- Founded2021
- HeadquartersAthens, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Liquet Technologies does
Liquet Technologies is a privately held ophthalmic medical device company headquartered at 1627 Enterprise Street in Athens, Texas. It was spun off from parent MED-LOGICS, Inc. in Q4 2021 to commercialize the CataPulse® Lens Removal System, a CE-approved cataract surgery platform that uses High Frequency Pulsed Vacuum technology operating at 450-800 pulses per minute. The system gently dissects and aspirates cataract material at the handpiece tip without generating frictional heat, addressing endothelial cell loss — a key limitation of traditional ultrasound phacoemulsification. Clinical study data on 73 subjects reported zero adverse events, an average 2.86% endothelial cell loss at 30 days, and 93% of patients achieving 20/30 or better uncorrected visual acuity.
The product platform comprises capital equipment (CataPulse Console CP1700, Footswitch CP1800, Cart CP1900), pre-assembled single-use disposable kits (Lens Removal Kit CP2100, Anterior Vitrectomy Kit CP2200), and a broad line of stainless steel and disposable bimanual and coaxial cannulas, plus the co-developed CataPulse Mini-Prechopper (CP3000). Manufacturing takes place in a Class 7 Cleanroom in Athens, Texas, under an ISO 13485:2016 quality system certified by British Standards Institute.
Liquet generates revenue through one-time hardware sales of the capital console ecosystem and recurring per-procedure sales of disposable kits and cannulas. Go-to-market is executed by Surgical Specialists who travel globally to recruit international distributors and sell directly to cataract surgeons, supplemented by training and post-sale clinical support. The company leverages MED-LOGICS' mature distribution chain selling into 70+ countries for LASIK and donor cornea products as its primary channel. Customer segments are cataract surgeons and the hospitals/surgical centers where they operate. Leadership comprises CEO Justin Ross (former MED-LOGICS operations lead), COO Tom Mancuso (ex-Diamatrix), and CSO Hal Walbrink (12 healthcare startups, $1B+ combined revenue).
Liquet Technologies firmographics
Firmographics- Name
- Liquet Technologies
- Legal name
- Liquet Technologies
- Website
- https://liquettechnologies.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Liquet Technologies is an Athens, Texas-based ophthalmic medical device company that manufactures the CE-approved CataPulse® Lens Removal System, a cataract surgery platform using High Frequency Pulsed Vacuum technology, serving cataract surgeons and surgical centers globally via direct sales and inherited MED-LOGICS distribution.
- Ownership category
- akta.pro rank
Liquet Technologies industry classification
Industry- Product category
- Ophthalmic Surgical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Ophthalmic Goods Manufacturing (339115)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
- akta.pro secondary industry
- Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF)
Keywords
Where Liquet Technologies is headquartered
LocationHeadquarters
- HQ city
- Athens
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Liquet Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- CataPulse Capital Equipment Sales: Sale of durable capital equipment including the CataPulse Console (CP1700), Footswitch (CP1800), and Cart (CP1900). These are one-time hardware purchases that enable the disposable products revenue stream.
- Disposable Surgical Products: Recurring revenue from single-use disposable products including Lens Removal Kits (CP2100), Anterior Vitrectomy Kits (CP2200), and various surgical cannulas (aspiration, irrigation, cortex removal) in stainless steel and disposable variants.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Liquet Technologies product offering
Product offeringCore offering
Liquet Technologies manufactures and sells the CataPulse® Lens Removal System, a CE-approved ophthalmic device using proprietary High Frequency Pulsed Vacuum (450-800 pulses per minute) technology for cataract removal. The product line includes capital equipment (Console CP1700, Footswitch CP1800, Cart CP1900) sold to surgeons and surgical centers, alongside recurring single-use disposable Lens Removal Kits, Anterior Vitrectomy Kits, surgical cannulas (aspiration, irrigation, cortex removal), and the Mini-Prechopper used during cataract surgery procedures.
Product overview
Liquet Technologies is a medical device company that offers the CataPulse® Lens Removal System as its core product platform. The system uses High Frequency Pulsed Vacuum technology for cataract surgery and includes the Console (CP1700), Footswitch (CP1800), and Cart (CP1900) as equipment components, along with single-use disposable kits including the Lens Removal Kit (CP2100) and Anterior Vitrectomy Kit (CP2200), plus a comprehensive line of stainless steel and disposable cannulas (aspiration, irrigation, and cortex removal in various gauges) and the Mini-Prechopper (CP3000). The company also markets legacy products from parent company MED-LOGICS including the ML7® Microkeratome for LASIK and donor cornea products. All products are manufactured in a Class 7 Cleanroom facility in Athens, Texas.
Differentiator
Problem solved
Functional benefit
Products and services
- CataPulse® Lens Removal System CE-approved cataract removal platform using proprietary High Frequency Pulsed Vacuum technology (450-800 pulses per minute) that gently dissects and aspirates cataract material at the handpiece tip without frictional heat, reducing endothelial cell loss compared to traditional phacoemulsification. The system includes the CataPulse Console (CP1700) with large touch screen, CataPulse Footswitch (CP1800) with four ergonomic buttons and linear vacuum pedal, and CataPulse Cart (CP1900) mobile stand with adjustable IV pole. Sold as durable capital equipment to cataract surgeons, hospitals, and ambulatory surgical centers.
- CataPulse® Lens Removal Kit (CP2100) Single-use, pre-assembled disposable kit for cataract surgery including aspiration handpiece, irrigation handpiece, fluid collection cassette, and sterile screen cover. Designed for one-time use, eliminating disassembly, cleaning, sterilization, and reassembly between procedures and simplifying OR workflow.
- CataPulse® Anterior Vitrectomy Kit (CP2200) Single-use, pre-assembled anterior vitrectomy handpiece and fluid collection cassette capable of 2,500 cuts per minute, used for removing vitreous humor from the anterior chamber when capsule rupture occurs during cataract surgery.
- CataPulse® Cannula Line Comprehensive range of stainless steel and disposable bimanual and coaxial surgical cannulas for cataract surgery, including aspiration cannulas (19G and 20G with 30° and 45° downward bevels), 2-port and 3-port irrigation cannulas with various gauge options, cortex removal cannulas (Simcoe Style with 0.30mm, 0.35mm, and 0.40mm ports), cortical irrigation cannulas (21G and 23G), and coaxial lens removal cannulas with irrigation sleeves for single-handpiece cataract removal.
- CataPulse® Mini-Prechopper (CP3000) Prechopper instrument developed in partnership with Duckworth and Kent in the UK, specifically designed to fit small bimanual incisions for the CataPulse system. It cuts into the cataract material along the central axis and expands to physically separate the cataract into multiple pieces.
Quantifiable outcome
- 2.86% average endothelial cell loss at day 30 post-op (vs. higher rates with traditional phaco)
- +3 more outcomes
Companies that use Liquet Technologies
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Liquet Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Liquet Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Duckworth and KentminorDuckworth and Kent, based in the UK, developed the CataPulse® Mini-Prechopper specifically designed to fit in the small bimanual incisions for the CataPulse system. The prechopper cuts into the cataract material along the central axis and expands to physically separate the cataract into multiple pieces.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Liquet Technologies competitors and assessment
Company assessmentBroad incumbents
- Hoya Surgical Optics: Provides IOLs and ophthalmic surgical devices for cataract surgery, competing for surgeon mind-share and OR share in the same cataract procedure economics.
- Alcon: Global leader in cataract surgical equipment (Centurion, Infiniti phaco systems), IOLs, and ophthalmic disposables — the dominant incumbent against which any novel cataract removal modality must compete.
- Johnson & Johnson Vision: Through its AMO/Acquisition portfolio, J&J Vision offers the Whitestar Signature phacoemulsification platform alongside its TECNIS IOLs — directly competes in cataract surgical devices and consumables.
- Carl Zeiss Meditec: Provides ophthalmic surgical microscopes and the Visalis V500 cataract surgery platform; competes in the cataract OR with integrated imaging, phaco, and consumables.
Direct peers
- BVI Medical: Acquired LenSx and offers the Stellaris Elite and other phaco systems in cataract surgery; competes head-on with Liquet for cataract OR capital equipment and disposable kits.
- DORC International: Dutch Ophthalmic Research Center offers combined cataract/vitrectomy systems (e.g., Eva) and surgical disposables, a direct competitor in the surgical instrumentation space for cataract and anterior vitrectomy cases.
- Nidek: Japanese ophthalmic equipment manufacturer offering phacoemulsification and vitrectomy platforms and a broad line of surgical disposables — directly comparable to CataPulse in product scope.
Emerging players
- STAAR Surgical: Specializes in IOLs (including phakic IOLs) and ophthalmic surgical devices; a peer in cataract surgical product categories with overlap in ophthalmic disposables.
- Rhein Medical (a Katalyst Surgical company): Develops and supplies ophthalmic surgical instruments and disposables, including cannulas and handpieces used in cataract surgery — an emerging peer in the same disposable-instrument category.
Regional players
- Diamatrix: Cataract instrument company where COO Tom Mancuso previously operated for 20 years; produces bimanual/aspiration cannulas and cataract surgical instruments highly comparable to Liquet's catalog.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Liquet Technologies social profiles
Digital presenceLiquet Technologies compliance and trust
Trust signalCompliance5 records
Liquet Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Liquet Technologies leadership team
Management profileNumber of profiles
Profiles3 records
Liquet Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Liquet Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Liquet Technologies
What does Liquet Technologies do?
Liquet Technologies manufactures and sells the CataPulse® Lens Removal System, a CE-approved ophthalmic device using proprietary High Frequency Pulsed Vacuum (450-800 pulses per minute) technology for cataract removal. The product line includes capital equipment (Console CP1700, Footswitch CP1800, Cart CP1900) sold to surgeons and surgical centers, alongside recurring single-use disposable Lens Removal Kits, Anterior Vitrectomy Kits, surgical cannulas (aspiration, irrigation, cortex removal), and the Mini-Prechopper used during cataract surgery procedures.
Is Liquet Technologies a public or private company?
Liquet Technologies is a private company. It is classified as corporate owned and is currently operating.
When was Liquet Technologies founded?
Liquet Technologies was founded in 2021. It employs 1 to 10 people.
Where is Liquet Technologies based?
Liquet Technologies is headquartered in Athens, United States, in the North America region.
How does Liquet Technologies make money?
Two revenue lines are on record. CataPulse Capital Equipment Sales are the primary driver. The others are disposable Surgical Products.
Who are Liquet Technologies's main competitors?
Broad incumbents on record are Hoya Surgical Optics, Alcon, Johnson & Johnson Vision and Carl Zeiss Meditec. Direct peers are BVI Medical, DORC International and Nidek. Emerging players are STAAR Surgical and Rhein Medical (a Katalyst Surgical company). Diamatrix is listed as a regional player.
Does Liquet Technologies have an API?
No public API is recorded for Liquet Technologies.
What industry is Liquet Technologies in?
Liquet Technologies's product category is Ophthalmic Surgical Devices. Its primary akta.pro industry code is HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics), with a secondary code of HLAKAKAF, Cornea, External Disease & Refractive Surgery (LASIK/PRK). Its NAICS code is 339112 and its SIC code is 3841.